Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study: 临床惰性可导致2 型糖尿病患者新发视网膜病变或 …

S Osataphan, T Chalermchai… - Journal of …, 2017 - Wiley Online Library
背景: 临床惰性是指不能根据循证指南成功地对患者进行强化治疗, 它可能对2
型糖尿病患者具有短期和长期不良的影响. 当前这项研究的目的是为了证实临床惰性对血糖控制 …

Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study

S Osataphan, T Chalermchai, K Ngaosuwan - Journal of Diabetes, 2017 - infona.pl
Background Clinical inertia is a failure to intensify treatment according to evidence‐based
guidelines, and can have both short‐and long‐term adverse effects for type 2 diabetes …

[引用][C] Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study

S Osataphan, T Chalermchai, K Ngaosuwan - Journal of Diabetes, 2016 - cir.nii.ac.jp
Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A
retrospective cohort study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study

S Osataphan, T Chalermchai, K Ngaosuwan - 2017 - ir.swu.ac.th
Background: Clinical inertia is a failure to intensify treatment according to evidence-based
guidelines, and can have both short-and long-term adverse effects for type 2 diabetes (T2D) …

Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study.

S Osataphan, T Chalermchai, K Ngaosuwan - Journal of Diabetes, 2016 - europepmc.org
Background Clinical inertia is a failure to intensify treatment according to evidence-based
guidelines, and can have both short-and long-term adverse effects for type 2 diabetes (T2D) …

Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study

S Osataphan, T Chalermchai… - Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Clinical inertia is a failure to intensify treatment according to evidence-based
guidelines, and can have both short-and long-term adverse effects for type 2 diabetes (T2D) …